Skip to main content
. 2016 Aug 25;95(11):1825–1832. doi: 10.1007/s00277-016-2787-7

Table 1.

Characteristics of healthy controls and patients with MPN

Sweden China
Controls MPN Controls MPN
Number 756 126 101 101
Age (years)
 Mean ± SD 64 ± 5 64 ± 14 58 ± 15 58 ± 15
 Median (range) 64 (54–74) 65 (25–106) 60 (17–82) 60 (17–82)
 Sex [%females] 53 53 50 50
MPN subtype, n (%)
 PV 41 (32.5) 16 (15.8)
 ET 40 (31.7) 38 (37.6)
 PMF 28 (22.3) 15 (14.9)
 MPN-NOS 17 (13.5) 32 (31.7)
JAK2-status, n (%)
 JAK2 V617F 60 (47.6) 38 (37.6)
 JAK2 V617F+ 66 (52.4) 56 (55.4)
 Unknown 0 7 (7.0)
CALR mutation 45 Unknown

MPN myeloproliferative neoplasm, PV polycythemia vera, ET essential thrombocythemia, PMF primary myelofibrosis